Structure-based development of a subtype-selective orexin 1 receptor antagonist

Proceedings of the National Academy of Sciences of the United States of America
Jan HellmannPeter Gmeiner

Abstract

Orexins are neuropeptides that activate the rhodopsin-like G protein-coupled receptors OX1R and OX2R. The orexin system plays an important role in the regulation of the sleep-wake cycle and the regulation of feeding and emotions. The nonselective orexin receptor antagonist suvorexant has been the first drug on the market targeting the orexin system and is prescribed for the treatment of insomnia. Subtype-selective OX1R antagonists are valuable tools to further investigate the functions and physiological role of the OX1R in vivo and promising lead compounds for the treatment of drug addiction, anxiety, pain or obesity. Starting from the OX1R and OX2R crystal structures bound to suvorexant, we exploited a single amino acid difference in the orthosteric binding site by using molecular docking and structure-based drug design to optimize ligand interactions with the OX1R while introducing repulsive interactions with the OX2R. A newly established enantiospecific synthesis provided ligands showing up to 75-fold selectivity for the OX1R over the OX2R subtype. The structure of a new OX1R antagonist with subnanomolar affinity (JH112) was determined by crystallography in complex with the OX1R and corresponded closely to the docking-predic...Continue Reading

References

Apr 8, 1995·The Veterinary Record·D A Gunn-MooreT J Gruffydd-Jones
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·L de LeceaJ G Sutcliffe
Nov 20, 1998·FEBS Letters·P TrivediX M Guan
Oct 31, 2000·Neuron·T C ThannickalJ M Siegel
May 23, 2001·The Journal of Comparative Neurology·J N MarcusJ K Elmquist
Aug 16, 2005·Nature·Glenda C HarrisGary Aston-Jones
Jul 22, 2006·The Journal of Pharmacology and Experimental Therapeutics·Terry KenakinChristian Watson
Aug 15, 2006·Nature Structural & Molecular Biology·Céline GalésMichel Bouvier
Feb 15, 2007·Nature Reviews. Neuroscience·Takeshi Sakurai
Apr 25, 2009·Nature Protocols·Martin Caffrey, Vadim Cherezov
Dec 16, 2010·Biophysical Journal·Billy BretonMichel Bouvier
Feb 18, 2011·Journal of Chemical Information and Modeling·Mark McGann
Mar 7, 2012·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C E Perez-LeightonC M Kotz
Jun 7, 2012·Journal of Computer-aided Molecular Design·Mark McGann
Sep 14, 2012·Neuropharmacology·Luyi ZhouRonald E See
May 23, 2013·British Journal of Pharmacology·R MouldC J Langmead
Jul 31, 2013·Bioorganic & Medicinal Chemistry Letters·Terry P LeboldBrock T Shireman
Aug 2, 2013·British Journal of Pharmacology·J P Kukkonen, C S Leonard
Feb 4, 2014·Journal of Computer-aided Molecular Design·Georgia McGaugheyPaul J Coleman
Nov 26, 2014·Expert Opinion on Investigational Drugs·Nava Zisapel
May 20, 2015·European Journal of Pharmacology·Sang-Min LeeAugen A Pioszak
Sep 1, 2015·Journal of Medicinal Chemistry·Anthony J RoeckerPaul J Coleman
Mar 8, 2016·Nature Structural & Molecular Biology·Jie YinDaniel M Rosenbaum
Aug 18, 2016·Nature·Aashish ManglikBrian K Shoichet
Apr 1, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bibi Marjan Razavi, Hossein Hosseinzadeh
Jun 1, 2017·The Journal of Pharmacology and Experimental Therapeutics·Carsten Theodor BeuckmannHiroyuki Higashiyama
Jul 1, 2017·The Journal of Pharmacology and Experimental Therapeutics·Alexander TreiberFrancois Jenck
Oct 28, 2017·Nature Reviews. Drug Discovery·Alexander S HauserDavid E Gloriam
Jan 25, 2018·Journal of Medicinal Chemistry·Florent ChevillardPeter Kolb
Jul 14, 2018·Frontiers in Molecular Neuroscience·Chunmei WangJing Chen
Aug 28, 2018·Brain Research·David A Perrey, Yanan Zhang
Nov 9, 2018·Proceedings of the National Academy of Sciences of the United States of America·Hongtao LiuPeter Gmeiner
Dec 21, 2019·Journal of Medicinal Chemistry·Mathieu RappasJohn A Christopher
Feb 26, 2020·Drugs·Lesley J Scott

❮ Previous
Next ❯

Citations

Jul 17, 2021·Trends in Pharmacological Sciences·Ellen GulezianSunyia Hussain
Sep 27, 2020·Journal of Medicinal Chemistry·Jakub GuneraPeter Kolb
Aug 28, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Couvineau AlainVoisin Thierry
Oct 31, 2021·Pharmacological Reviews·Jennifer A KrickerMichael J Parnham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.